Citius Pharmaceuticals, Inc. Proceeds from Issuance of Warrants
Citius Pharmaceuticals, Inc. (CTXR) had Proceeds from Issuance of Warrants of $9.00 million as of 2025-09-10, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-08-14
- Citius Pharmaceuticals, Inc. proceeds from issuance of warrants for the quarter ending 2021-09-30 was $0.00.
- Citius Pharmaceuticals, Inc. proceeds from issuance of warrants for the quarter ending 2021-06-30 was $16.89M.
- Citius Pharmaceuticals, Inc. proceeds from issuance of warrants for fiscal 2021 was $31.13M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 3 month | Proceeds from Issuance of Warrants 6 month | Proceeds from Issuance of Warrants 9 month | Proceeds from Issuance of Warrants 12 month |
|---|---|---|---|---|---|
| 2025-09-10 | $9.00M 10-Q · filed 2026-08-14 | ||||
| 2025-07-17 | $9.00M 10-Q · filed 2026-08-14 | ||||
| 2025-06-11 | $6.00M 10-Q · filed 2026-08-14 | ||||
| 2025-04-01 | $2.00M 10-Q · filed 2026-08-14 | ||||
| 2025-01-11 | $6.00M 10-K · filed 2025-12-23 | ||||
| 2024-04-30 | $15.00M 10-K · filed 2024-12-27 | ||||
| 2023-06-30 | $875.00K 10-Q · filed 2023-08-14 | ||||
| 2023-05-08 | $15.00M 10-Q · filed 2024-08-12 | ||||
| 2021-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-12-22 | $16.89M derived: sum of 2 quarters · filed 2022-12-22 | $31.13M 10-K · filed 2022-12-22 | ||
| 2021-06-30 | $16.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-11 | $31.13M 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | $14.24M 10-Q · filed 2022-05-12 | ||||
| 2017-06-30 | $190.89K 10-Q · filed 2018-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |